Adding cognitive behavioral therapy (CBT) to the antipsychotic quetiapine for the treatment of mood disorders outperformed quetiapine alone for reduced risk for suicide, improved depressive symptoms, ...
EurekAlert!: Slowing cognitive decline in major depressive disorder and mild cognitive impairment
Persistent depressive disorder, known as dysthymia or low-grade depression, is less severe than major depression but more chronic. It occurs twice as often in women as in men. Persistent depressive ...
Monthly Prescribing Reference: FDA Clears Prescription Digital Therapeutic for Major Depressive Disorder
Magnetic seizure therapy appeared to beneficial for the treatment of major depressive disorder with fewer memory-related risks.
Healio: Arrivo Bio initiates phase 2b trial of SIRT6 activator for major depressive disorder
Please provide your email address to receive an email when new articles are posted on . The clinical trial of SP-624 is expected to enroll 450 patients with major depressive disorder. The primary ...
Arrivo Bio initiates phase 2b trial of SIRT6 activator for major depressive disorder
clinicaladvisor.com: Quetiapine Plus CBT Reduces Suicide Risk in Adults With Mood Disorders
Adjunctive CBT vs quetiapine monotherapy led to greater improvements in depressive symptoms. Adding cognitive behavioral therapy (CBT) to quetiapine vs quetiapine alone significantly reduces suicide ...
Integrate SFT with CBT, ACT, Narrative Therapy, and digital tools to enhance flexibility, client engagement, and outcome-based care. Build and grow your own future-focused SFT-based private practice or coaching business with authenticity, intention, and lasting impact.
Multiple Sclerosis News Today: CBT effective for MS depression, but requires upkeep: Study
CBT, done face-to-face, online, or by phone, eases depression in MS after two months, but it may need to be repeated within six months.